ArticleMolecules (Basel, Switzerland)2022
Novel 4-Azapregnene Derivatives as Potential Anticancer Agents: Synthesis, Antiproliferative Activity and Molecular Docking Studies.
Vanessa Brito, Adriana Oliveira Santos, Gilberto Alves, Paulo Almeida, Samuel Silvestre
Open access · goldAbstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors at 1 institution in 1 country.
Vanessa BritoHealth Sciences Research Centre (CICS-UBI), Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0002-8030-9379 Adriana Oliveira SantosHealth Sciences Research Centre (CICS-UBI), Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
Gilberto AlvesHealth Sciences Research Centre (CICS-UBI), Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0002-4213-0714 Paulo AlmeidaHealth Sciences Research Centre (CICS-UBI), Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0003-0110-4795 Samuel SilvestreHealth Sciences Research Centre (CICS-UBI), Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0003-4297-5108 University of Beira Interior · PT
Funding
BID/ICI-FC/Santander Universidades-UBI/2016 BID/ICI-FC/Santander Universidades-UBI/2016C4-Cloud Computing Competences Center CENTRO-01-0145-FEDER-000019FEDER funds through the POCI - COMPETE 2020 - Operational Programme Competitiveness and Internationalization in Axis I - Strengthening Research, Technological Development and Innovation Project No. 007491FEDER through COMPETE 2020, POCI and PORL and FCT through PIDDAC Project No. 022161Foundation for Science and Technology Project UID/ Multi/00709Fundação para a Ciência e Tecnologia SFRH/BD/131059/ 2017
6 · The paper itselfAbstract
Indexed as
Antineoplastic AgentsReceptors, AndrogenAndrogensAzasteroidsCell Line, TumorCell ProliferationCholestenone 5 alpha-ReductaseDrug Screening Assays, AntitumorEstrogen Receptor alphaMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipAndrogensAntineoplastic AgentsAzasteroidsCholestenone 5 alpha-ReductaseEstrogen Receptor alphaReceptors, Androgen4-azapregnenes4-azasteroidsaldol condensationantiproliferative activitymolecular docking
Identifiers
PMID36144856
PMCPMC9501232
OpenAlexW4296742284
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390